9040-61-3

Basic information

• Product Name: Recombinant Staphylokinase
• Synonyms: Recombinant Staphylokinase;Staphylokinase
• CAS NO: 9040-61-3
• Molecular Weight: 0
• Product Categories: enzyme
• Mol File: 9040-61-3.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Recombinant Staphylokinase(CAS DataBase Reference)
• NIST Chemistry Reference: Recombinant Staphylokinase(9040-61-3)
• EPA Substance Registry System: Recombinant Staphylokinase(9040-61-3)

Safety Data

• Hazardous Substances Data: 9040-61-3(Hazardous Substances Data)

Usage

Description

Recombinant Staphylokinase is a biologically engineered form of the protein staphylokinase, which is produced by Staphylococcus aureus bacteria. It is known for its ability to dissolve blood clots and is being studied for its potential use as a thrombolytic agent in the treatment of conditions such as myocardial infarction and stroke. Recombinant Staphylokinase is produced using genetic engineering techniques, allowing for more consistent and scalable production compared to natural sources. This form of staphylokinase has shown promise in clinical trials for its ability to effectively dissolve blood clots and improve outcomes for patients with clot-related conditions.

Uses

Used in Pharmaceutical Industry:
Recombinant Staphylokinase is used as a thrombolytic agent for the treatment of conditions such as myocardial infarction and stroke. It is effective in dissolving blood clots, which can help restore blood flow and reduce the damage caused by these clot-related conditions.
Used in Research and Development:
Recombinant Staphylokinase is also used in research and development for the study of blood clotting mechanisms and the development of new treatments for clot-related conditions. Its consistent and scalable production through genetic engineering techniques makes it an ideal candidate for research purposes.
Used in Clinical Trials:
Recombinant Staphylokinase is used in clinical trials to evaluate its safety and efficacy as a thrombolytic agent. These trials help to determine the optimal dosage, administration methods, and potential side effects of the treatment, ultimately contributing to its potential approval and use in medical practice.